These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21324086)

  • 1. Conventional vs. extended-cycle oral contraceptives on the quality of sexual life: comparison between two regimens containing 3 mg drospirenone and 20 µg ethinyl estradiol.
    Caruso S; Iraci Sareri M; Agnello C; Romano M; Lo Presti L; Malandrino C; Cianci A
    J Sex Med; 2011 May; 8(5):1478-85. PubMed ID: 21324086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary study on the effect of four-phasic estradiol valerate and dienogest (E2V/DNG) oral contraceptive on the quality of sexual life.
    Caruso S; Agnello C; Romano M; Cianci S; Lo Presti L; Malandrino C; Cianci A
    J Sex Med; 2011 Oct; 8(10):2841-50. PubMed ID: 21810188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of sexual life of women on oral contraceptive continued-regimen: pilot study.
    Caruso S; Malandrino C; Cicero C; Ciancio F; Cariola M; Cianci A
    J Sex Med; 2013 Feb; 10(2):460-6. PubMed ID: 23171201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study on sexual behavior of women using 30 microg ethinylestradiol and 3 mg drospirenone oral contraceptive.
    Caruso S; Agnello C; Intelisano G; Farina M; Di Mari L; Sparacino L; Cianci A
    Contraception; 2005 Jul; 72(1):19-23. PubMed ID: 15964287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clitoral vascularization and sexual behavior in young patients treated with drospirenone-ethinyl estradiol or contraceptive vaginal ring: a prospective, randomized, pilot study.
    Battaglia C; Morotti E; Persico N; Battaglia B; Busacchi P; Casadio P; Paradisi R; Venturoli S
    J Sex Med; 2014 Feb; 11(2):471-80. PubMed ID: 24299553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding profile of a flexible extended regimen of ethinylestradiol/drospirenone in US women: an open-label, three-arm, active-controlled, multicenter study.
    Jensen JT; Garie SG; Trummer D; Elliesen J
    Contraception; 2012 Aug; 86(2):110-8. PubMed ID: 22281416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective follow-up of two 21/7 cycles followed by two extended regimen 84/7 cycles with contraceptive pills containing ethinyl estradiol and drospirenone.
    Seidman DS; Yeshaya A; Ber A; Amodai I; Feinstein I; Finkel I; Gordon N; Porat N; Samuel D; Shiran-Makler E; Wolman I
    Isr Med Assoc J; 2010 Jul; 12(7):400-5. PubMed ID: 20862819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: a comparison of two triphasic formulations containing norgestimate and either 35 or 25 microg of ethinyl estradiol.
    Greco T; Graham CA; Bancroft J; Tanner A; Doll HA
    Contraception; 2007 Jul; 76(1):8-17. PubMed ID: 17586130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen.
    Coffee AL; Sulak PJ; Kuehl TJ
    Contraception; 2007 Jun; 75(6):444-9. PubMed ID: 17519150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of sexual life in hyperandrogenic women treated with an oral contraceptive containing chlormadinone acetate.
    Caruso S; Rugolo S; Agnello C; Romano M; Cianci A
    J Sex Med; 2009 Dec; 6(12):3376-84. PubMed ID: 19832931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptives and premenstrual symptoms: comparison of a 21/7 and extended regimen.
    Coffee AL; Kuehl TJ; Willis S; Sulak PJ
    Am J Obstet Gynecol; 2006 Nov; 195(5):1311-9. PubMed ID: 16796986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A historical cycle control comparison of two drospirenone-containing combined oral contraceptives: ethinylestradiol 30 μg/drospirenone 3 mg administered in a 21/7 regimen versus ethinylestradiol 20 μg/drospirenone 3 mg administered in a 24/4 regimen.
    Marr J; Gerlinger C; Kunz M
    Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):91-5. PubMed ID: 22391750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive.
    Caruso S; Iraci M; Cianci S; Fava V; Casella E; Cianci A
    J Endocrinol Invest; 2016 Aug; 39(8):923-31. PubMed ID: 27023105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexual behavior and oral contraception: a pilot study.
    Battaglia C; Battaglia B; Mancini F; Busacchi P; Paganotto MC; Morotti E; Venturoli S
    J Sex Med; 2012 Feb; 9(2):550-7. PubMed ID: 22188640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of cycle control, side effects and client's satisfaction of a low dose combined contraceptive containing ethinylestradiol/drospirenone (24/4 regimen).
    Chaiyasit N; Taneepanichskul S
    J Med Assoc Thai; 2010 May; 93(5):517-22. PubMed ID: 20524436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined hormonal contraception in cycles artificially extended].
    Bustillos-Alamilla E; Zepeda-Zaragoza J; Hernández-Ruiz MA; Briones-Landa CH
    Ginecol Obstet Mex; 2010 Jan; 78(1):37-45. PubMed ID: 20931801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleeding pattern, tolerance and patient satisfaction with a drospirenone-containing oral contraceptive evaluated in 3488 women in Europe, the Middle East and Canada.
    Endrikat JS; Milchev NP; Kapamadzija A; Georgievska J; Gerlinger C; Schmidt W; Feroze S
    Contraception; 2009 Jun; 79(6):428-32. PubMed ID: 19442777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of an oral contraceptive containing drospirenone in an extended regimen.
    Sillem M; Schneidereit R; Heithecker R; Mueck AO
    Eur J Contracept Reprod Health Care; 2003 Sep; 8(3):162-9. PubMed ID: 14667328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.